RevBio gets $2M to develop bone graft with pain drug
RevBio has received a $2 million grant to fund the preclinical development of a bone graft that will release locally acting nonopioid pain medication. Its
RevBio has received a $2 million grant to fund the preclinical development of a bone graft that will release locally acting nonopioid pain medication. Its
Dentists reported that pediatric pain management practices need to improve, because controlling pain, as well as anxiety or fear, in kids is a problem. The
Scuderia Ferrari driver Charles Leclerc was experiencing pain from a tooth infection, which he suspected was coming from a wisdom tooth, when he competed at
The University of Missouri (MU) has received a grant to train healthcare workers, including dentists, virtually to work with patients who experienced adverse childhood events
Though dental patients are less likely to be prescribed opioids today than they were a few years ago, U.S. dentists and oral surgeons in 2022
Spike Lee, PhD, of the University of Toronto’s Rotman School of Management, had just received a numbing agent, like he always does before a dental
Cannabidiol (CBD), a nonaddictive, nonpsychoactive component of the marijuana plant, may reduce severe dental pain, making it a safer, equally effective alternative to opioids. The
The University of New England (UNE) College of Dental Medicine, led by the Harvard School of Dental Medicine (HSDM), has received a $4.4 million grant
Using intermaxillary elastics with clear aligners in adults may cause temporomandibular joint disorders (TMDs) or worsen symptoms or pain associated with them. The study was
Of the nearly 60 interventions or combination of treatments available to treat chronic jaw pain, only a few like exercises and psychotherapy were likely the
Scoliosis may predispose patients to temporomandibular disorders (TMDs). The study, which was published in early December in Clinical Radiology, is believed to be the first
The U.S. Patent and Trademark Office has issued a patent to Balanced Pharma for its dental anesthesia cartridge technology. BPI-001, the company’s new drug candidate,